Total Payments
$11,355
2024 Payments
$2,876
Companies
29
Transactions
316
Medicare Patients
849
Medicare Billing
$228,300
Payment Breakdown by Category
Food & Beverage$11,140 (98.1%)
Consulting$215.03 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,140 | 311 | 98.1% |
| Consulting Fee | $215.03 | 5 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,330 | 76 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,580 | 77 | $0 (2024) |
| Amgen Inc. | $838.46 | 18 | $0 (2024) |
| ADMA BioManufacturing LLC | $726.01 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $614.34 | 22 | $0 (2024) |
| GENZYME CORPORATION | $510.82 | 11 | $0 (2024) |
| Blueprint Medicines Corporation | $458.48 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $453.74 | 13 | $0 (2024) |
| Genentech USA, Inc. | $435.50 | 12 | $0 (2024) |
| BioCryst US Sales Co., LLC | $434.27 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,876 | 92 | AstraZeneca Pharmaceuticals LP ($1,116) |
| 2023 | $2,335 | 60 | AstraZeneca Pharmaceuticals LP ($638.10) |
| 2022 | $2,543 | 61 | AstraZeneca Pharmaceuticals LP ($497.45) |
| 2021 | $1,077 | 38 | AstraZeneca Pharmaceuticals LP ($246.55) |
| 2020 | $734.91 | 23 | AstraZeneca Pharmaceuticals LP ($276.65) |
| 2019 | $1,589 | 37 | AstraZeneca Pharmaceuticals LP ($555.05) |
| 2018 | $200.02 | 5 | Regeneron Healthcare Solutions, Inc. ($140.33) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Inflammation | ||||||
| 12/19/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: BIOLOGIC | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: GENETIC DISEASE | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Immunology | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: GENETIC DISEASE | ||||||
| 11/13/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $44.01 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $89.63 | General |
| 11/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Immunology | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $81.09 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $94.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $35.50 | General |
| Category: Immunology | ||||||
| 10/14/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 339 | 5,825 | $460,795 | $141,249 |
| 2022 | 7 | 162 | 1,874 | $72,204 | $19,144 |
| 2021 | 9 | 208 | 2,881 | $132,225 | $51,600 |
| 2020 | 7 | 140 | 1,372 | $57,971 | $16,307 |
Total Patients
849
Total Services
11,952
Medicare Billing
$228,300
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 12 | 3,735 | $338,985 | $113,079 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 94 | $31,727 | $10,882 | 34.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 37 | 1,545 | $26,352 | $5,406 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $15,075 | $3,888 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $7,850 | $2,433 | 31.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 173 | $16,670 | $2,298 | 13.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 40 | 47 | $8,505 | $1,097 | 12.9% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 13 | 82 | $2,758 | $671.84 | 24.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 18 | 18 | $5,625 | $612.27 | 10.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 11 | 11 | $2,750 | $548.45 | 19.9% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 15 | 16 | $1,348 | $242.30 | 18.0% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 34 | 42 | $3,150 | $90.82 | 2.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 35 | 1,685 | $26,960 | $6,055 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $14,299 | $5,337 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 42 | $11,784 | $4,557 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 20 | $3,809 | $1,711 | 44.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 52 | $9,710 | $643.57 | 6.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 16 | 18 | $3,780 | $461.48 | 12.2% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 18 | 23 | $1,862 | $377.52 | 20.3% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2021 | 13 | 1,005 | $60,300 | $31,440 | 52.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $19,085 | $7,357 | 38.6% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 36 | 1,672 | $26,752 | $6,180 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 25 | $7,000 | $2,933 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 19 | $3,610 | $1,610 | 44.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 50 | $9,250 | $708.69 | 7.7% |
About Dr. Stephen Marks, M.D
Dr. Stephen Marks, M.D is a Allergy & Immunology healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437120235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Marks, M.D has received a total of $11,355 in payments from pharmaceutical and medical device companies, with $2,876 received in 2024. These payments were reported across 316 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($11,140).
As a Medicare-enrolled provider, Marks has provided services to 849 Medicare beneficiaries, totaling 11,952 services with total Medicare billing of $228,300. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy
- Location Anchorage, AK
- Active Since 01/30/2006
- Last Updated 04/15/2025
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1437120235
Products in Payments
- TEZSPIRE (Biological) $1,874
- NUCALA (Biological) $995.43
- FASENRA (Drug) $744.25
- Xolair (Biological) $682.08
- DUPIXENT (Biological) $669.57
- BREZTRI (Drug) $623.62
- AYVAKIT (Drug) $458.48
- TRELEGY ELLIPTA (Drug) $425.92
- FASENRA (Biological) $392.40
- AIRSUPRA (Drug) $336.49
- CUVITRU (Biological) $324.49
- ORLADEYO (Drug) $293.30
- TAKHZYRO (Biological) $249.61
- CINRYZE (Drug) $200.47
- ACTIMMUNE (Drug) $179.45
- XOLAIR (Biological) $173.90
- Orladeyo (Drug) $140.97
- DUPIXENT DUPILUMAB INJECTION (Biological) $140.33
- Haegarda (Biological) $114.22
- CUTAQUIG (Biological) $103.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Anchorage
Jeffrey Demain, M.d, M.D
Allergy & Immunology — Payments: $161,862
Allergy & Immunology $161,862
Dr. Melinda Rathkopf, M.d, M.D
Allergy & Immunology — Payments: $18,749
Allergy & Immunology $18,749
Dr. Eric Meier, M.d, M.D
Allergy & Immunology — Payments: $17,604
Allergy & Immunology $17,604
David Hemry, Md, MD
Allergy & Immunology
Allergy & Immunology